molmir was nominated to participate in the J-StarX program which delegates entrepreneurs to overseas community, initiated by JETRO, Japan External Trade Organization and METI, Ministry of Economy, Trade and Industry of Japan. BioUK is an advanced course, “supporting specific industry and limited number of participants to delegate in order to conduct international fundraise as well as customer acquisition.” 6 Japanese startups were selected.
The program was hosted by MedCity in order to help participants gain insights about life science ecosystem in the UK and its market. On January 28th, COO Yamamoto has delivered a pitch at Demo Day in front of the UK life sciences stake holders at London for the first time to improve our global recognition for the first time overseas.
Healthcare and drug developments are the industries led by major nations among Europe and North America. molmir keeps working on our global expansion further more by leveraging the established connections we forged with the British startups, governmental bodies as well as pharmaceutical companies we met through this program.
